Our immune system relies on nanomachines, such as the membrane attack complex (MAC) to kill invasive bacteria in our blood. Our research, published in the EMBO journal and Nature Communications, provides us with a better understanding of how the immune system kills bacteria. This may guide the development of new therapies that harness the immune system against bacterial infections, and strategies that repurpose the immune system to act against other rogue cells in the body.
The cover of the current issue of ACS Synthetic Biology highlights the our collaborative research project with UCL Chemistry and the National Physical Laboratory to engineer a programmable inside-out “virus”. This everted “virus” is designed to deliver functional proteins into live cells.
